knowledge -WSS

knowledge

author：entertainment 2025-09-30 01:14:17 - browse：436

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Medical device lobby: We're tired of waiting on Medicare coverage

leisure time

Wikipedia

WSS

In search for therapies for solid tumors, companies turn to claudin

Chemotherapy drug shortage eases slightly but still widespread

ALS groups 'won't be played again' by the FDA, drug sponsors

Kenai launches with $82 million for Parkinson’s stem cell therapy

Flu vaccine offering decent levels of protection this winter, new data show

Why getting cancer drugs just got harder for rural patients

focus

knowledge

explore

Hollywood unions extend contract negotiations for actors

What to expect at HLTH 2023, the health care industry conference

Virginia high school admissions case could be legal follow

Kenai launches with $82 million for Parkinson’s stem cell therapy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Chan Zuckerberg Biohub Chicago to focus on inflammation

New air purifier tech could be key to improving indoor air quality

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Walensky prepares to leave CDC — and Congress — behind

AI can decode, harness the power of the humane immune system

hotspot

RSV vaccines may be linked to small increased risk of developing GBS

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Bill would stop addiction treatment from triggering child abuse inquiry